Medications

ACE inhibitor/ARB use not tied to COVID-19 test positivity

(HealthDay)—Angiotensin-converting enzyme inhibitor (ACEI) and/or angiotensin receptor blocker (ARB) use is not associated with COVID-19 test positivity, according to a study published online May 5 in JAMA Cardiology.

Medical research

Gel allows for targeted therapy after heart attack

(Medical Xpress)—Combatting the tissue degrading enzymes that cause lasting damage following a heart attack is tricky. Each patient responds to a heart attack differently and damage can vary from one part of the heart muscle ...

Diseases, Conditions, Syndromes

A new target in the fight against TB

(Medical Xpress)—Researchers have identified a potential new route for attacking tuberculosis that may hold promise against drug-resistant strains of the disease and even dormant TB infections.

Health

Meds up hospitalization for dehydration, heat-linked illness

(HealthDay)—Among veterans, initiation of many commonly-used medications is associated with increased risk of hospitalization for dehydration or heat-related illness, according to research published online July 4 in the ...

Oncology & Cancer

Scientists gain new insights into Taspase1 function

Scientists at the University Medical Center of Johannes Gutenberg University Mainz in Germany identified a novel strategy to target the oncologically relevant protein-cleaving enzyme Taspase1. Taspase1 levels are not only ...

Other

Enzyme-inhibition could revolutionize molecular imaging

The prominent role a single enzyme plays in cancer imaging has eluded researchers for years, but not anymore. This discovery could pave new avenues in nuclear medicine. The enzyme, called neutral endopeptidase (NEP), has ...

page 5 from 6